Research on antibiotics and the bacteria they target. Covers antibiotic resistance, gut pathogens, persistent strep throat, and water-source contamination.
A study by Brigham and Women's Hospital found that patients with primary care received more high-value care, such as cancer screening and diagnostic testing, and reported a better healthcare experience. Primary care was also associated with higher rates of recommended counseling services, including smoking cessation.
Researchers have solved a 20-year riddle of how crucial step in antibiotic biosynthesis occurs, opening way to potentially redesigning antibiotics. The team structurally characterised the peptide bond forming domain in Ebony enzyme, revealing its novel types of condensation domain and its role in regulating neurotransmitters.
A new study has confirmed the presence of a superbug gene in the Kongsfjorden region of Svalbard, one of the last pristine places on Earth. The blaNDM-1 gene, originally found in urban India, has been detected in Arctic soils and is associated with increased antibiotic resistance.
A study in the Journal of Antimicrobial Chemotherapy found that providing more information about how doctors prescribe drugs can reduce problems associated with overprescription. Between 2012 and 2017, there was a notable decrease of 14% in antibiotic prescriptions in England.
Researchers in Leicester are investigating the use of antibiotics to treat certain types of severe asthma, a condition affecting 1 in 20 people with asthma. The study aims to identify patients with specific subtypes of severe asthma and test new oral treatments, including doxycycline and dexpramipexole.
A team of researchers isolated a peptide named emericellipsin A from soil fungi, which possesses antitumor and antibacterial properties. The substance was proved to be effective against various types of bacteria and fungi, including those resistant to other antibiotics.
A new antibiotic called Ramizol shows promise in treating drug-resistant bacteria in the intestines, particularly for Clostridium difficile infection (CDI). The research indicates that Ramizol is well-tolerated and effective against lethal doses of the bacteria.
Researchers developed a rapid whole genome sequencing method that can identify specific antibiotic-resistant bacteria strains in under a day, reducing treatment time by at least 20 hours. The technology has the potential to speed personalized treatment of drug-resistant infections, which claim thousands of lives annually.
Bronchiolitis, a common viral lung infection, is often treated with antibiotics in US emergency rooms, contradicting evidence-based guidelines. The study found that 25% of children under 2 years old with bronchiolitis received antibiotics between 2007 and 2015.
A nearly 30-year mystery has been solved by Rutgers and international scientists, who discovered the molecular machinery that produces potent antibiotic microcin B17. The findings provide tools to design new antimicrobials and anticancer drugs.
A comprehensive US study found only 13% of outpatient antibiotic prescriptions were appropriate, highlighting the widespread overuse of antibiotics. The study used a novel classification scheme and evaluated all 91,738 diagnosis codes in ICD-10, categorizing each for antibiotic appropriateness.
Between 2008 and 2016, antibiotic prescribing by dermatologists declined overall, driven largely by a decrease in extended courses for acne and rosacea. However, the use of postoperative antibiotics after surgical visits increased, raising concerns that practice should be evaluated
A recent study published in The BMJ found that nearly a quarter of antibiotic prescriptions for privately insured outpatients in the US were inappropriate. Inappropriate prescribing was more common among adults than children, with colds, chest infections, and coughs being the three most common reasons.
A new study found that nearly a quarter of antibiotic prescriptions for children and adults may be unnecessary, with 1 in 7 patients receiving antibiotics for cases that were not medically justified. This highlights the need to reduce antibiotic overuse and its consequences, including contributing to antibiotic-resistant bacteria.
The article highlights the need for accurate evaluation of documented penicillin allergies, which can be safely treated in most cases. The JAMA report provides guidance on comprehensive history taking and risk assessment, recommending a simple history to distinguish intolerances from allergies.
Researchers developed a mobile CRISPRi system to study antibiotic function in various bacteria, including those that cause disease and promote health. The system allows scientists to screen for antibiotic targets thousands of genes at once, providing clues on how to improve existing antibiotics or develop new ones.
New research suggests that taking non-steroidal anti-inflammatory drugs (NSAIDs) for pain can increase the risk of severe Clostridium difficile infections. The study found that brief exposure to an NSAID prior to infection worsened infection severity and shortened survival in mice.
A recent study published in Nature Communications reveals a strong correlation between
Researchers have discovered a previously unknown strain of bacteria in ancient Irish soil that effectively inhibits the growth of four top-six multi-resistant pathogens. The strain, Streptomyces sp. myrophorea, has shown promise against gram-positive and gram-negative bacteria, providing new hope for combating antibiotic resistance.
A new study found that antibiotics are being overused in up to 50% of patients undergoing common urological procedures, with extended use following the procedure being the main issue. This excessive use can promote antibiotic resistance and expose patients to potential harm.
Chemical synthesis breakthrough offers hope in combating lethal drug-resistant infections; researchers develop efficient, scaleable antibiotics to fight Staphylococcus aureus and other bacterial species.
A large study found that widespread, low-intensity antibiotic use in the US is more closely linked to antibiotic resistance than high-intensity use by a small fraction of the population. The study analyzed data from over 60 million Americans and found that occasional use was associated with higher rates of resistance.
Qualitative analyses suggest vaccine-based strategies can outperform antibiotic-centered approaches in certain cases, limiting AMR spread and preserving the human microbiome. Vaccine development is crucial to address growing AMR concerns, as indicated by studies highlighting vaccines' potential economic benefits.
Researchers discovered that a drug initially developed for Alzheimer's disease has antibacterial properties, potentially breaking antibiotic resistance in bacteria. The findings suggest the drug could be repurposed to treat infectious diseases.
Bacteria adapt more slowly and less efficiently when exposed to two stress factors, leading to smaller population sizes. This affects the evolution of antibiotic resistance, as bacteria are less able to protect themselves from predators, resulting in a stronger influence on their survival rate.
Researchers at MIT created variants of a wasp venom peptide that are potent against bacteria while nontoxic to human cells. The peptides were designed by analyzing the structure and function of the original molecule, identifying optimal percentages of hydrophobic amino acids and positively charged amino acids.
Scientists at Imperial College London discovered that persister cells manipulate immune cells, potentially opening new avenues to clearing these cells from the body. The study found that persisters weaken the power of macrophages, a key part of our arsenal against infection.
A study by Duke University researchers shows that pathogen responses to first-line antibiotics can be distinguished, allowing for more effective treatment strategies. The researchers developed a method to quantify resistance and resilience, enabling clinicians to prescribe targeted dosing regimens.
A nationwide Danish study found a significant increase in postoperative infections, pneumonia, and community-based antibiotics after hip fracture surgery between 2005 and 2016. The risk of hospital-treated infections increased by 32% and pneumonia by 70%, with higher risks among elderly patients.
A global review of antibiotic sales in 70 high- and middle-income countries found that consumption patterns vary widely, with low levels of 'Access' antibiotics like amoxicillin. The study also highlights the overuse of 'Watch' antibiotics, which should only be used for specific indications.
Researchers found that 10 essential oils, including garlic oil, showed significant killing activity against 'persister' forms of Lyme disease bacteria. The study suggests these plant compounds may be more effective than current antibiotics in treating persistent Lyme symptoms.
Researchers developed nanoparticles that detect proteases produced by bacteria and immune cells, allowing for faster diagnosis of pneumonia. The sensors can indicate whether antibiotics are effective in treating the infection.
Researchers developed a rapid diagnostic tool using a small, inexpensive biosensor to provide instant and accurate results. The device can detect bacteria and screen their interaction with antibiotics, giving healthcare practitioners more information for accurate treatment decisions.
Researchers at NC State University have developed a virtual library of 1 million new macrolide scaffolds, which can help speed up the discovery of new antibiotics and cancer drugs. The library was created using computer simulation software that generates compounds with desirable properties.
Researchers found that certain antibiotics can alter the way bacteria divide and interact with each other, leading to increased competence and the spread of antibiotic-resistant genes. Biofilms play a crucial role in this process, allowing cells to secrete higher concentrations of a peptide that triggers quorum sensing.
Researchers discovered an enzymatic reaction cascade generating the essential 6-membered ring in mupirocin production. The finding builds on earlier research and could lead to the development of new antibiotics with improved properties.
Researchers have discovered a new chemical process in bacteria that could lead to the development of new antibiotics. The biosynthetic pathway includes an enzyme called carboxylase, which adds CO2 to a precursor molecule producing a highly unusual antibiotic called malonomycin.
Researchers at Ruhr-Universität Bochum have identified a small RNA molecule that significantly affects antibiotic resistance in soil bacteria. Without this molecule, the bacteria are more sensitive to penicillins and produce less of the enzyme degrading these antibiotics.
Researchers found that antibiotic prophylaxis regimens are less effective at preventing surgical site infections following colorectal surgery. The efficacy of antibiotic prophylaxis has remained unchanged for other procedures like appendectomy and cesarean section.
A survey of 2,537 US adults found that roughly half believe the average person faces a serious health risk from food additives over their lifetime. Similarly, about half think genetically modified foods are worse for one's health. Women and those with low science knowledge tend to express more concern about these issues.
Thanatin, a natural insect antibiotic, eliminates bacteria by preventing the formation of their outer protective shield. This unprecedented mechanism offers a new way to develop effective antibiotics against dangerous pathogens like Pseudomonas aeruginosa and Escherichia coli.
A study by Stanford University researchers found that surgery remains the best treatment option for appendicitis, despite being more expensive upfront. Patients treated with antibiotics alone had higher rates of hospital readmissions and abdominal abscesses, highlighting the risks of this alternative approach.
A team of researchers from the University of Bristol has identified a key component of the antibiotic binding mechanism of VIM proteins, which protects bacteria from beta-lactam antibiotics. This discovery provides insights into how antibiotics can be designed to block the activity of these resistance mechanisms.
A new system, CAMR-R, can measure antimicrobial resistant phenotypes at single-cell resolution from clinical samples in three hours without cell propagation. The instrument uses D2O-feeding Raman Microspectroscopy to quantify AMR levels and has potential applications in diagnosing clinical pathogens.
Scientists will develop a catalogue of simplified synthetic teixobactin molecules to combat superbugs like MSRA and VRE. The project aims to create new antibiotics for human use, addressing the high failure rate in drug development.
Researchers have published the first estimates of antibiotic and pesticide planetary boundaries, revealing that Gram-negative bacteria are already beyond these limits. The study emphasizes the urgent need for new approaches to manage resistance, including promoting susceptibility to pesticides and antibiotics.
A combination therapy of polymyxin B/trimethoprim has shown promising results against bacterial keratitis, a leading cause of blindness. The treatment eradicated infections in 70% of animal models and showed a low rate of spontaneous resistance.
A study published in Applied and Environmental Microbiology found that antibiotic-resistant E. coli bacteria in wild giraffes most likely come from anthropogenic sources. The research suggests that young giraffes are more likely to harbor resistant bacteria, potentially due to competition between strains.
Research reveals Salmonella species, causing foodborne diseases, are resistant to multiple antibiotic classes. The study identified 39 genes linked to this resistance, shedding light on the epidemiology of salmonellosis in Brazil.
A new set of generic competencies has been established by ESCMID to guide healthcare professionals in using antibiotics responsibly. The competencies cover three main areas: antimicrobial prescribing, diagnosing infections, and stewardship. This framework aims to harmonize approaches to antibiotic use across Europe.
A new antibiotic, zoliflodacin, has shown promising results in treating uncomplicated gonorrhea infections with a single oral dose. The study found a cure rate of 96% for participants treated with zoliflodacin, compared to 100% for those treated with ceftriaxone.
A Phase 2 clinical trial found that zoliflodacin cured most cases of uncomplicated gonorrhea, with cure rates ranging from 98% to 100%, depending on the dose. The antibiotic also showed promise in treating rectal and throat infections, although performance varied between doses.
Two Virginia Tech professors, Amy Pruden and Marc Edwards, are leading studies on antibiotic resistance in recycled water and plumbing. Their research aims to identify effective disinfectants and designs for preventing the spread of resistant bacteria in water systems, a growing concern that affects public health.
Most cystic fibrosis patients do not achieve high enough antibiotic concentrations in their blood to effectively fight bacteria responsible for pulmonary exacerbations. Real-time monitoring of serum antibiotic concentrations could help improve clinical outcomes and reduce worsening pulmonary function.
Researchers attach molecular attachment r8 to conventional antibiotics, helping them penetrate bacterial outer defenses and linger, increasing effectiveness against methicillin-resistant Staphylococcus aureus (MRSA). The approach demonstrates potential for treating other drugs and infections with existing modifications.
A survey found that nearly three-quarters of parents keep leftover antibiotics and give them to others, including siblings and unrelated adults. The practice, called prescription diversion, increases the risk of antibiotic-resistant infections.
Researchers found kanglemycins, a group of natural antibiotics similar to rifamycin, which can target mutated RNAPs. These antibiotics may have emerged as a result of evolutionary pressures in nature, providing a potential solution to the rising problem of antibiotic resistance.
A nationwide network study has found a small association between early antibiotic exposure and weight gain in young children. The research, published in Pediatrics, suggests that antibiotic use at less than 24 months of age may lead to slightly higher body weight at 5 years of age.
A large study of over 333,000 infants found that exposure to antibiotics and acid suppressants in early childhood may increase the risk of obesity by age 3. The research suggests an association between these drugs and altered gut microbiomes linked to weight gain.
Patients with drug-resistant urinary tract infections are more likely to experience worse clinical outcomes and relapses within a week. The study highlights the importance of close follow-up and proper antibiotic treatment to curb antibiotic resistance.